Sentences with phrase «types of breast cancer patients»

Breast conserving therapy (BCT, breast conserving surgery combined with radiation therapy) is superior to mastectomy in certain types of breast cancer patients, according to results from the largest study to date, to be presented to the European Cancer Congress 2017 today (Monday).

Not exact matches

The experimental drug nintedanib, combined with standard chemotherapy with paclitaxel, causes a total remission of tumours in 50 % of patients suffering from early HER - 2 - negative breast cancer, the most common type of breast cancer.
Fior and colleagues plan to do that with a larger group of colorectal cancer patients and with patients who have other types of cancer, such as breast cancer.
«Our findings suggest that this new drug combination would also help patients with this type of aggressive breast cancer as well as other cancers, such as lung, prostate and ovarian cancers,» Dr. Rassool says.
Assessed patients had a range of cancer types, with the most common types being breast cancer (44 %), prostate cancer (15 %), and colorectal cancer (14 %), and the average time since cancer diagnosis was 13.5 months.
When breast cancer is diagnosed, the drug regimen that the patient receives is based primarily on the results of a biopsy that is used to identify the type of tumor she has.
Dr. Parda, who practices oncology in Pittsburgh, says that many types of physicians are likely to be a part of a patient's cancer care team including a medical oncologist, breast surgeon, surgical oncologist, plastic surgeon, and radiation oncologist as well as their ob / gyn.
Previous in vitro studies conducted by researchers in other countries showed that this molecule was able to reduce the multiplication and increase the mortality of cells from melanoma, the most aggressive type of skin cancer, as well as breast cancer and neuroblastoma, a tumor that typically affects patients aged 15 or younger.
They also showed that drugs against a type of breast tumor called HER2 positive breast cancer — such as the dual ERBB2 / EGFR inhibitor lapatinib — potentially could benefit more patients than currently receive them, if analysis of the tumor proteins is taken into consideration.
Additionally, the prognosis for patients with TNBC is usually poorer than for those with other types of breast cancers.
«Triple - negative breast cancers tend to be more aggressive compared to other types of breast cancers, and being able to predict response to therapy could greatly impact treatment decisions and patient outcomes,» says study author Shaveta Vinayak, MD, oncologist at UH Case Medical Center and Assistant Professor at Case Western Reserve University School of Medicine.
The researchers found that weight is most closely linked to tumours that are «endocrine - receptor positive» - the most common type of breast cancer, affecting 75 per cent of patients.
«Agents that block the proteins — CDK4 / 6 inhibitors — have received Food and Drug administration approval for some patients with metastatic breast cancer, but they've also shown promise against others types of tumors in clinical trials.
A research team, led by Chao Cheng, Ph.D., Assistant Professor in the Department of Genetics at The Geisel School of Medicine at Dartmouth, used gene expression data from breast cancer patients to computationally infer the presence of different types of immune cells.
Depending on characteristics such as how many tumor cells, blood vessel cells, and immune cells are touching each other, the tumor microenvironment can nearly triple the chance that a common type of breast cancer (estrogen - receptor positive / HER2 negative) that has reached the lymph nodes will also metastasize, Condeelis and colleagues showed in a 2014 study of 3,760 patients.
These are usually personalised to the patient and are selected based on the type of breast cancer, the site and extent of spread as well as the patient's decision as to what treatments are acceptable to them.
Biologists from more than two dozen institutions analyzed DNA from 11,000 cancer patients with 33 major types of the disease, including breast and pancreatic cancer.
The challenge is that these mutations are «personal» to the tumor and patient; i.e., not all types of breast cancer carry the same set of mutations, and as a result, different patients have a different, personal set of mutations.
Breast cancer treatment regimens differ widely based on the type of cancer, its stage, its sensitivity to hormones, the patient's age and health, and other factors.
More advanced types of breast cancers do have a significantly lower survival rate; thus the outlook for many patients may be unpleasant.
In many cases, physicians will find that the patient also has a ductal carcinoma in situ tumor, but there are some patients that are also diagnosed with an invasive type of breast cancer when a physician find that they have developed Paget disease.
I ask my patients about contraindications including blood clots, pregnancy, moderate to severe endometriosis, enlarging fibroids or associated with heavy bleeding, gallbladder disease, liver disease (because the liver processes estrogen and sends it to the gut via bile), unexplained vaginal bleeding, atypical hyperplasia of the breast, some types of estrogen - sensitive breast cancer, endometrial cancer, ovarian cancer.
JAMA even recently published an article discussing its utility in weight loss and type 2 diabetes, both closely related to several common cancers like breast and prostate cancer.9 This effect, in itself, may improve cancer outcomes since weight gain is associated with an increased risk of recurrence and death, thus the mediccal should seriously consider the ketogenic diet, periodic ketosis, or simply low - carb to help patients achieve and maintain a healthy weight and healthy metabolic status.10 After years of taking continuous shots for their views, the modern day pioneers like Jeff Volek are finally receiving some vindication.
It helps patients suffering from a wide spectrum of chronic diseases that are related to poor lifestyle choices, including obesity, type 2 diabetes, and several types of cancer, such as prostate, breast, and colon.
In each issue, she learns something along these lines: «When a patient has this type of breast cancer, I currently do X.
Patients were diagnosed with various types of cancer, including breast (54 %), gynecological (11 %), skin (9 %), hematological (8 %), urological (5 %), soft tissue and bone tumors (5 %), head / neck (3 %), gastrointestinal (3 %) and central nervous system (2 %).
a b c d e f g h i j k l m n o p q r s t u v w x y z